BEAM: beamtx.com Company Aggregate Debts

Symbol and logo of brand Beam Therapeutics (BEAM)

By leveraging established DNA material logistics through its laboratory network, Beam Therapeutics Inc. (BEAM) maintains high profitability. The GURU.Markets platform transmits debt dynamics, where 0.24 reflects the latest metric value. Quotes depend on BEAM-101 trials and lipid nanoparticles, while the environmental profile is limited by strict bio-waste control at research centers.

Beam Therapeutics - BEAM Company Aggregate Debts (period 07/04/2022 - 10/30/2026)

Metric breakdowns and analytics for Beam Therapeutics (BEAM)

- stock price and consensus target price:
Share Price Beam Tx|BEAM - Analyst Consensus Forecast
- market capitalization information:
Market Capitalization Beam Therapeutics Corp|BEAM - Enterprise Value
- balance sheet equity data:
Net Assets per Single Share Beam Therapeutics|BEAM - Book Capitalization|Market-to-Book Ratio beamtx.com|BEAM - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Beam Therapeutics Inc.|BEAM - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Beam Therapeutics Inc|BEAM - Company Total Debt|Debt to Net Assets Ratio Beam Therapeutics Corp|BEAM - Company Long-Term Liabilities|Amount of Current Liabilities Beam Therapeutics|Intermediate Coverage Ratio beamtx.com
- financial results and valuation multiples details:
BEAM - Net Profit
Summary company analytics:Beam Tx, BEAM
Signature product of Beam Therapeutics Corp

This indicator aggregates all short-term and long-term liabilities, allowing the investor to assess the total debt load and the risk of insolvency. The dynamics of the leverage ratio reflect the balance between securing external financing and its repayment, which is critically important for Beam Therapeutics Inc. (BEAM), as negative operating cash flow during the development stage necessitates rigorous control over the liability structure.

Who Beam Therapeutics Inc. competes with

Tempus AI, Inc. - Company Aggregate Debt|Company Aggregate Debts QGEN (Qiagen N.V.)|Company Aggregate Debts ionispharma.com IONS|Repligen - Company Aggregate Debts|RNA: Company Debts|CRSP: Company Aggregate Debts|Company Cumulative Debt GeneDx Corp (WGS)|RARE (Ultragenyx Pharmaceutical) - Company Aggregate Debts|Company Aggregate Debts sarepta.com|Company Debts Twist Bioscience, Inc. (TWST)|Company Total Debt 10x Genomics Inc TXG|Intellia - Company Total Debt|Aggregate Debt Obligations STOK|BLFS: Company Total Debt|wavelifesciences.com - Company Cumulative Indebtedness|MAZE: Company Aggregate Debts|Sionna Therapeutics, Inc. - Aggregate Debt Obligations|PRME (Prime Medicine Corp) - Company Aggregate Debts|Company Cumulative Debt Taysha Corp TSHA|Company Debts uniQure N.V. (QURE)|MGTX (meiragtx.com) - Aggregate Debt Obligations|Company Aggregate Debts RGNX (REGENXBIO)|Company Aggregate Debts Solid Biosciences Inc SLDB|OCGN - Company Debts|Company Aggregate Indebtedness PACB|BNTC: Company Aggregate Debts|Company Cumulative Debt designtx.com (DSGN)|Company Total Debt RCKT|Company Aggregate Debts 4DMT|Company Total Debt LXEO (Lexeo Therapeutics)|Company Cumulative Indebtedness KRRO|Company Aggregate Debts EDIT (Editas Medicine, Inc.)|Company Total Debt Obligations silence-therapeutics.com (SLN)|ProQR Therapeutics NV - Company Aggregate Debts|Codexis, Inc. (CDXS) - Company Total Debt|Sangamo (SGMO) - Company Debts|NAUT - Company Total Debt Obligations|Company Total Debt MGX|DTIL: Aggregate Debt Obligations|Company Aggregate Debts GBIO|Company Total Debt Obligations Boundless Bio Inc.|Company Debts Exicure XCUR|IMNN: Company Aggregate Debt|RXi Pharmaceuticals - Company Aggregate Debts|Mustang Bio, Inc. (MBIO) - Company Total Debt|RNAZ (transcodetherapeutics.com) - Company Total Debt|BNGO - Company Total Debt Obligations|APDN (Applied DNA) - Company Aggregate Debts|Company Debts BLUE|Company Aggregate Debts IPA|OMGA - Company Cumulative Debt|Company Aggregate Debts OMIC (Singular Genomics)|Company Aggregate Debts Regulus Therapeutics, Inc. RGLS|SYRS - Company Debts|Telesis Bio, Inc (TBIO) - Company Total Debt|TCON: Company Aggregate Debts|Company Aggregate Debt UBX